SOL vs. AIP, VLN, LAES, BKSY, TBCH, CAN, CRNT, VUZI, ATOM, and CSLR
Should you be buying Emeren Group stock or one of its competitors? The main competitors of Emeren Group include Arteris (AIP), Valens Semiconductor (VLN), SEALSQ (LAES), BlackSky Technology (BKSY), Turtle Beach (TBCH), Canaan (CAN), Ceragon Networks (CRNT), Vuzix (VUZI), Atomera (ATOM), and Complete Solaria (CSLR). These companies are all part of the "electronic equipment" industry.
Emeren Group vs.
Emeren Group (NYSE:SOL) and Arteris (NASDAQ:AIP) are both small-cap energy companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.
Emeren Group has a net margin of -7.14% compared to Arteris' net margin of -58.27%. Emeren Group's return on equity of -2.05% beat Arteris' return on equity.
Emeren Group has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, Arteris has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.
44.1% of Emeren Group shares are held by institutional investors. Comparatively, 64.4% of Arteris shares are held by institutional investors. 37.3% of Emeren Group shares are held by insiders. Comparatively, 33.7% of Arteris shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Emeren Group received 184 more outperform votes than Arteris when rated by MarketBeat users. However, 64.52% of users gave Arteris an outperform vote while only 45.43% of users gave Emeren Group an outperform vote.
Emeren Group has higher revenue and earnings than Arteris. Arteris is trading at a lower price-to-earnings ratio than Emeren Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Arteris had 2 more articles in the media than Emeren Group. MarketBeat recorded 3 mentions for Arteris and 1 mentions for Emeren Group. Arteris' average media sentiment score of 1.60 beat Emeren Group's score of -1.00 indicating that Arteris is being referred to more favorably in the news media.
Emeren Group currently has a consensus target price of $4.13, suggesting a potential upside of 226.09%. Arteris has a consensus target price of $12.75, suggesting a potential upside of 119.07%. Given Emeren Group's higher probable upside, equities analysts plainly believe Emeren Group is more favorable than Arteris.
Summary
Emeren Group beats Arteris on 10 of the 18 factors compared between the two stocks.
Get Emeren Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SOL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Emeren Group Competitors List
Related Companies and Tools
This page (NYSE:SOL) was last updated on 4/20/2025 by MarketBeat.com Staff
Buy SOL Stock Free SOL Stock Alerts